tiprankstipranks
Trending News
More News >
Arrail Group Ltd. (HK:6639)
:6639
Hong Kong Market

Arrail Group Ltd. (6639) AI Stock Analysis

Compare
1 Followers

Top Page

HK

Arrail Group Ltd.

(6639)

Rating:63Neutral
Price Target:
Arrail Group Ltd. demonstrates strong financial performance with robust cash flow and improving profitability, which are the main drivers of its stock score. Technical indicators suggest a bearish trend, although the stock may be oversold. The valuation appears stretched, limiting immediate upside potential. Overall, while the financial fundamentals are solid, market sentiment and valuation concerns temper the outlook.

Arrail Group Ltd. (6639) vs. iShares MSCI Hong Kong ETF (EWH)

Arrail Group Ltd. Business Overview & Revenue Model

Company DescriptionArrail Group Ltd. (6639) is a leading dental services provider based in China, specializing in high-quality dental care services. The company operates a network of dental clinics under two brands: Arrail Dental for premium services and Rytime Dental for affordable care. Arrail Group is committed to offering comprehensive dental solutions, including preventive, restorative, orthodontic, and aesthetic dental services, to meet diverse consumer needs.
How the Company Makes MoneyArrail Group Ltd. generates revenue primarily through the provision of dental services across its network of clinics. The company's key revenue streams include fees for dental consultations, treatments, and procedures offered under its Arrail Dental and Rytime Dental brands. Arrail Group benefits from its strategic positioning in the growing Chinese dental care market, leveraging its reputation for quality care and its extensive clinic network to attract a broad customer base. Additionally, partnerships with leading dental product suppliers and investment in cutting-edge dental technology contribute to its service offerings, enhancing customer satisfaction and loyalty, which in turn supports its revenue growth.

Arrail Group Ltd. Financial Statement Overview

Summary
Arrail Group Ltd. exhibits promising growth with improving profitability and strong cash flow generation. While financial stability is evident through a strong equity ratio, moderate leverage requires careful management. The company is on a positive trajectory but must continue enhancing profitability and managing debt to sustain growth.
Income Statement
72
Positive
Arrail Group Ltd. has shown strong revenue growth of 18.47% in the most recent year, signaling positive momentum. The gross profit margin improved to 22.49%, reflecting better cost management. However, the net profit margin is still low at 0.98%, indicating limited profitability. The turnaround in EBIT and EBITDA margins to 1.49% and 18.46%, respectively, from negative figures in prior years demonstrates improving operational efficiency.
Balance Sheet
65
Positive
The company has a healthy equity position with an equity ratio of 53.95%, denoting financial stability. However, the debt-to-equity ratio of 0.60 suggests moderate leverage which could pose risks if not managed carefully. The return on equity is modest at 0.98%, reflecting the need for enhanced profitability to generate better shareholder returns.
Cash Flow
78
Positive
Operating cash flow grew significantly, supporting a strong free cash flow growth rate of 686.08%. The operating cash flow to net income ratio of 16.12 demonstrates good cash generation relative to earnings. A solid free cash flow to net income ratio of 10.74 further underscores the company's capability to generate cash.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
1.75B1.75B1.47B1.62B1.52B1.10B
Gross Profit
364.84M392.68M247.08M336.56M364.42M111.39M
EBIT
4.61M26.00M-193.59M-38.55M126.19M-133.44M
EBITDA
93.34M322.35M87.85M42.10M207.44M-32.35M
Net Income Common Stockholders
20.83M17.16M-219.91M-701.03M-599.42M-316.85M
Balance SheetCash, Cash Equivalents and Short-Term Investments
997.94M1.10B937.53M1.26B727.31M249.72M
Total Assets
3.13B3.25B3.06B2.99B2.35B1.90B
Total Debt
1.05B1.05B955.68M890.67M1.03B945.14M
Net Debt
432.63M396.46M333.82M-161.61M356.30M772.53M
Total Liabilities
1.39B1.42B1.37B1.38B4.81B3.93B
Stockholders Equity
1.67B1.76B1.61B1.56B-2.50B-2.06B
Cash FlowFree Cash Flow
172.32M184.21M23.50M108.63M213.50M95.11M
Operating Cash Flow
217.17M276.65M131.66M224.28M242.87M154.29M
Investing Cash Flow
74.11M-176.00M-342.44M-203.94M61.75M-109.59M
Financing Cash Flow
-274.06M-106.96M-280.35M380.86M217.51M-43.85M

Arrail Group Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.18
Price Trends
50DMA
2.08
Positive
100DMA
2.26
Negative
200DMA
2.75
Negative
Market Momentum
MACD
0.02
Positive
RSI
51.26
Neutral
STOCH
53.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6639, the sentiment is Neutral. The current price of 2.18 is below the 20-day moving average (MA) of 2.20, above the 50-day MA of 2.08, and below the 200-day MA of 2.75, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 51.26 is Neutral, neither overbought nor oversold. The STOCH value of 53.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:6639.

Arrail Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$7.26B14.5112.58%4.04%5.69%-7.43%
66
Neutral
HK$746.68M21.000.66%1.59%169.20%
63
Neutral
HK$1.23B44.221.22%7.58%
58
Neutral
HK$315.03M15.012.73%3.37%-0.69%
54
Neutral
$5.37B3.26-45.10%3.30%16.81%0.02%
51
Neutral
$16.79B96.280.96%1.01%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6639
Arrail Group Ltd.
2.18
-3.43
-61.14%
HK:2138
EC Healthcare
0.63
-0.73
-53.68%
HK:1419
Human Health Holdings Ltd.
0.83
-0.16
-16.16%
HK:1833
Ping An Healthcare and Technology Company
7.77
3.70
90.86%
HK:3613
Beijing Tong Ren Tang Chinese Medicine Co
8.67
-0.29
-3.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.